ERA PerMed

As next step towards a European Partnership for Personalised Medicine, a drafting group was established by the Member States in close collaboration with the European Commission.

With support and guidance from the European Commission, they developed a draft proposal for the Partnership that was published by the European Commission in February 2022 in this link. 

The vision of the European Partnership for Personalised Medicine is: To improve health outcomes within sustainable healthcare systems through research, and the development and implementation of personalised medicine approaches for the benefit of patients, citizens and society.

This is a further step in the establishment and preparation of the partnership for personalised medicine, to be co-funded by the EC in the European Union’s 9th Framework Programme for Research and Innovation, Horizon Europe.

To realise its vision, the partnership will integrate all the elements needed in a collaborative effort to achieve the full potential of personalised medicine:

  • Generate research and results through funding activities for example via transnational and cross-sectorial research consortia, networks, pilots and collaborations. 
  • The partnership will be the most significant platform and initiative to connect key stakeholders in the personalised medicine field to share evidence, demonstrate solutions and to drive supportive activities in policy, regulatory science and health economics. 

The EP PerMed aims to align and promote national and regional priority setting and funding for research and implementation projects in the area of personalised medicine between the EU Member States (MS), regions and associated countries as well as international partner countries.

Please follow us on @ERANET_PerMed!